News

Researchers Discover Drug Target for Kidney Failure
March 11, 2012 
Mount Sinai researchers used computer software to help identify a protein that plays a crucial role in kidney fibrosis, which leads to kidney failure, a disease that affects millions of Americans.

Systems Biology Center New York Accepting Applications for the 2012 Summer Undergraduate Research Program
November 11, 2011 
City University of New York undergraduates interested in an intensive summer research training experience in computational systems biology are invited to apply.

Mount Sinai Researchers Develop New Computational Method to Aid Analysis of Gene Expression Experiments
September 15, 2010 
Mount Sinai researchers have developed a new database that will change how scientists identify drug targets and biomarkers.

Researchers Identify New Therapeutic Targets to Improve Pain Management After Chronic Morphine Administration
September 7, 2010 
Researchers identified changes in the brain and spinal cord that occur during the development of morphine tolerance, providing a therapeutic target for preventing it.

Mount Sinai Researchers Reveal Novel Structural Features at the Core of Cellular Energy Conversion
August 18, 2010 
The research team determined that the cellular nanomachine, or motor, uses a water molecule to convert food energy into usable cellular energy.

Mount Sinai Discovers Genetic Framework to Explain and Predict Adverse Drug Reactions
April 20, 2010 
Researchers at Mount Sinai School of Medicine have taken a step toward the ability to predict adverse drug reactions, such as heart arrhythmias.

Mount Sinai Research Team Leads NIH-Funded Project Examining the Mechanism of Human Tissue Assembly
September 24, 2009 
The $6 million, five-year grant awarded to the Dynamics Underlying Tissue Integrity project supports the collaborative research of a number of biomedical initiatives.

Center Director

Ravi Iyengar, PhDRavi Iyengar, PhD, is the Dorothy H. and Lewis Rosenstiel Professor and Chair of the Department of Pharmacology and Systems Therapeutics. Dr. Iyengar is Director of the Experimental Therapeutics Institute and Director and Principal Investigator of the Systems Biology Center New York.  Read More